Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 81.99 USD -1.04% Market Closed
Market Cap: 32.1B USD

Intrinsic Value

The intrinsic value of one DXCM stock under the Base Case scenario is 50.9 USD. Compared to the current market price of 81.99 USD, Dexcom Inc is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DXCM Intrinsic Value
50.9 USD
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dexcom Inc

Valuation History Unavailable

Historical valuation for DXCM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare DXCM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Dexcom’s dominant position in continuous glucose monitoring faces mounting pressure from Abbott’s Freestyle Libre, which offers lower-cost options and wider distribution, potentially diluting Dexcom’s market share and pricing power.

Bull Theses

Dexcom’s recognized best-in-class accuracy and brand loyalty in Type 1 diabetes management could preserve its premium pricing and reinforce market leadership despite competitive threats.

Show More Less
How do you feel about DXCM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Dexcom Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dexcom Inc

Current Assets 4.6B
Cash & Short-Term Investments 2.7B
Receivables 1.2B
Other Current Assets 682.5m
Non-Current Assets 2.2B
PP&E 1.4B
Intangibles 118.3m
Other Non-Current Assets 655.8m
Efficiency

Free Cash Flow Analysis
Dexcom Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dexcom Inc

Revenue
4.1B USD
Cost of Revenue
-1.6B USD
Gross Profit
2.5B USD
Operating Expenses
-1.9B USD
Operating Income
632.6m USD
Other Expenses
-97.4m USD
Net Income
535.2m USD
Fundamental Scores

DXCM Profitability Score
Profitability Due Diligence

Dexcom Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
64/100
Profitability
Score

Dexcom Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

DXCM Solvency Score
Solvency Due Diligence

Dexcom Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
79/100
Solvency
Score

Dexcom Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 101.72 USD with a low forecast of 82.82 USD and a high forecast of 120.75 USD.

Lowest
Price Target
82.82 USD
1% Upside
Average
Price Target
101.72 USD
24% Upside
Highest
Price Target
120.75 USD
47% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dexcom Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DXCM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DXCM Insider Trading
Buy and sell transactions by insiders

DXCM News

Other Videos
What is the Intrinsic Value of one DXCM stock?

The intrinsic value of one DXCM stock under the Base Case scenario is 50.9 USD.

Is DXCM stock undervalued or overvalued?

Compared to the current market price of 81.99 USD, Dexcom Inc is Overvalued by 38%.

Back to Top